Cite
Dartigeas C, Van Den Neste E, Berthou C, et al. Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2015;57(2):328-334doi: 10.3109/10428194.2015.1063139.
Dartigeas, C., Van Den Neste, E., Berthou, C., Maisonneuve, H., Leprêtre, S., Dilhuydy, M. S., Béné, M. C., Nguyen-Khac, F., Letestu, R., Cymbalista, F., De Guibert, S., Aurran, T., Laribi, K., Vilque, J. P., Tournilhac, O., Delmer, A., Feugier, P., Cazin, B., Michallet, A. S., Lévy, V., Troussard, X., Delepine, R., Tavernier, E., Colombat, P., & Leblond, V. (2016). Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia. Leukemia & lymphoma, 57(2), 328-334. https://doi.org/10.3109/10428194.2015.1063139
Dartigeas, Caroline, et al. "Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia." Leukemia & lymphoma vol. 57,2 (2016): 328-334. doi: https://doi.org/10.3109/10428194.2015.1063139
Dartigeas C, Van Den Neste E, Berthou C, Maisonneuve H, Leprêtre S, Dilhuydy MS, Béné MC, Nguyen-Khac F, Letestu R, Cymbalista F, De Guibert S, Aurran T, Laribi K, Vilque JP, Tournilhac O, Delmer A, Feugier P, Cazin B, Michallet AS, Lévy V, Troussard X, Delepine R, Tavernier E, Colombat P, Leblond V. Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2016 Feb;57(2):328-334. doi: 10.3109/10428194.2015.1063139. Epub 2015 Sep 28. PMID: 26140301.
Copy
Download .nbib